Trends in the Treatment of Grade III Diabetic Foot Ulcers (n=176)

In a recent micro survey designed by Michel H.E. Hermans, MD, Medical Director, 3S Consulting Group, Inc. and featured within the WOC Skin Health Weekly® digital publication, respondents were asked to report on the treatment of Grade III Diabetic Foot Ulcers.

“Grade III Diabetic Foot Ulcers” defined as deep ulcerations with cellulitis or abscess formation, often with osteomyelitis.

Approximately 83% of respondents reported that they routinely treated Grade III Diabetic Foot Ulcers.

Of those, 52% described their clinical certification as Would Ostomy Continence Nurse. The average number of years of experience in treating Grade III Diabetic Foot Ulcers ranged between 5-10 years.

The Wound Clinic (43%) is the clinical setting in which Grade III Diabetic Foot Ulcers were treated most often, followed by the Hospital (28%) and Home Health Care (11%).

When debridement is indicated, Sharps (surgical) (68%) was selected most often for Grade III Diabetic Foot Ulcers, followed by Enzymatic (18%) and Autolytic (8%).

Type of Debridements

Those who selected Sharps debridement reported the reason for the selection as the “Need for rapid debridement” (63%), “Large amount of necrosis/slough” (16%), and “Minimal trauma to healthy tissue” (6%).

Those who selected Enzymatic debridement reported the reason for selection as “Ease of use” (25%), “Minimal disturbance to the wound and Peri-wound tissue” (21%) and “Minimal trauma to healthy tissue” (21%) most often.

Those who selected Autolytic debridement reported the reason for selection as “Ease of use” (45%), “Minimal disturbance to the wound and Peri-wound tissue” (18%) and “Minimal trauma to healthy tissue” (18%).

Silver dressings were utilized most often as the primary wound dressing for the management of Grade III Diabetic Foot Ulcers (27%) . “Primary” is defined as the dressing which is applied directly to the wound bed.

dressing

Those who selected Silver dressings as the primary dressing reported the reason for selection as “Decrease bioburden/biofilm” (50%), “Positive patient outcomes” (15%), and “Accelerate healing” (9%).

Those who selected Other (cadexomer iodine, enzymatic, lodosorb gel, etc.) as the primary dressing reported the reason for selection as “Positive patient outcomes” (29%), “Other” (29%), and “Accelerate healing” (21%).

Those who selected Negative Pressure Wound Therapy (NPWT) as the primary dressing reported the reason for selection as “Accelerate healing” (57%), and “Positive patient outcomes” (29%).

Please contact your 3S Account Executive if you are interested in more in-depth research on Trends in the Treatment of Diabetic Foot Ulcers.